Systematic review of atypical hemolytic uremic syndrome biomarkers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology,Pediatrics, Perinatology and Child Health
Link
https://link.springer.com/content/pdf/10.1007/s00467-022-05451-2.pdf
Reference81 articles.
1. Noris M, Caprioli J, Bresin E, Mossali C et al (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844–1859. https://doi.org/10.2215/CJN.02210310
2. Yoshida Y, Kato H, Ikeda Y, Nangaku M (2019) Pathogenesis of atypical hemolytic uremic syndrome. J Atheroscler Thromb 26:99–110. https://doi.org/10.5551/jat.RV17026
3. Moake JL (2002) Thrombotic Microangiopathies. N Engl J Med 347:589–600. https://doi.org/10.1056/NEJMra020528
4. Oh J, Oh D, Lee SJ, Kim JO, Korean TTP Registry Investigators et al (2019) Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura. Blood Res 54:218–228. https://doi.org/10.5045/br.2019.54.3.218
5. Kato H, Nangaku M, Hataya H, Sawai T et al (2016) Clinical guides for atypical hemolytic uremic syndrome in Japan. Clin Exp Nephrol 20:536–543. https://doi.org/10.1007/s10157-016-1276-6
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma;Clinica Chimica Acta;2024-02
2. Inborn errors of immunity with kidney and urinary tract disorders: a review;International Urology and Nephrology;2024-01-10
3. Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults;Frontiers in Medicine;2023-12-01
4. Renal Thrombotic Microangiopathy: A Review;American Journal of Kidney Diseases;2023-05
5. Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab;Molecular Diagnosis & Therapy;2022-11-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3